Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

ACTION · Aggression in Children: Unraveling gene-environment interplay to inform Treatment and InterventiON strateg

FP7Status: CLOSED1 June 201431 May 2019EU funding €5,999,079

Aggression inflicts a huge personal, psychological and financial burden on affected individuals, their relatives, and society at large. Despite large scientific, preventive, and treatment investments, no decrease in aggressive behavior is seen. This calls for a shift to new approaches. By capitalising on comprehensive longitudinal cohorts, recent advances in genetic, biological, epidemiological, and clinical fields, and combining such interdisciplinary expertise the ACTION consortium will dissect the etiology and pathogenesis of aggression. Based on new insights, ACTION will inform the development of novel diagnostic tools and causative targets and guide the development of treatment and prevention strategies. ACTION is built on interrelated work packages with a focus on a) clinical epidemiology and current classification and treatment problems; b) genetic epidemiology, including Genome Wide Association studies and epigenetics; c) gene-environment correlation and interaction; d) biomarkers and metabolomics. ACTION will deliver an overarching framework that combines a thorough understanding of pathways leading to aggression with a map of current gaps, best practices on clinical, ethical, legal, and social issues. Based on this framework, ACTION will develop novel biomarkers suitable for large-scale applications in children and combine biomarker data with new insights into the effects of gender, age, and comorbidity. ACTION will provide guidance in optimising current intervention programs and deliver new biological targets to pave the way for novel therapeutic interventions. ACTION will provide a decision tree to guide personalised intervention programmes and will have direct and sustained impact on reducing paediatric aggression. Its overarching aim is to reduce aggression by developing approaches that take individual differences in genetic and environmental susceptibility into account, thereby leading to better understanding of personalised intervention programs.

Consortium · 12 organisations

coordinator

STICHTING VU

NL · €1,697,459

participant

ACADEMISCH ZIEKENHUIS LEIDEN

NL · €392,100

participant

GOOD BIOMARKER SCIENCES BV

NL · €894,963

participant

UNIVERSITEIT LEIDEN

NL · €419,452

participant

HELSINGIN YLIOPISTO

FI · €496,720

participant

DIAGENODE

BE · €22,267

participant

University of Notre Dame du Lac

US · €270,009

participant

UNIVERSITA DEGLI STUDI DI CAGLIARI

IT · €475,947

participant

QUEENSLAND INSTITUTE OF MEDICAL RESEARCH

AU

participant

KAROLINSKA INSTITUTET

SE · €501,280

participant

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM

NL · €278,700

participant

KING'S COLLEGE LONDON

UK · €550,183

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.